Epigenomics Closes 21M Series C Round

Apr 03, 2003

NEW YORK, April 3 - Epigenomics has closed a Series C round of financing worth €21 million, or around $ 22.5 million, the company said today.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.